Tuesday, March 21, 2006

Favrille treatment

After scaling to a 52-week high last week, bio-pharmeceutical stock FVRL closed at $6.63. Recent insider buying is of note (2.1-million shares), but volume in Favrille Inc's stock picked up considerably last week. The stock is back near its high today, trading at $7.50 at midday.
 
 
 
Post a Comment